Hanquet, Germaine
Theilacker, Christian
Vietri, Jeffrey
Sepúlveda-Pachón, Ingrid
Menon, Sonia
Gessner, Bradford
Begier, Elizabeth http://orcid.org/0000-0002-1287-5416
Funding for this research was provided by:
Pfizer Inc.
Article History
Received: 19 December 2023
Accepted: 22 February 2024
First Online: 18 March 2024
Declarations
:
: Germaine Hanquet and Ingrid Sepúlveda-Pachón are employees of P95 Epidemiology & Pharmacovigilance, which was contracted by Pfizer to conduct the research described in this manuscript and for manuscript development. Sonia Menon was an employee of P95 Epidemiology & Pharmacovigilance at the time of contributing to the research; her current affiliation is Epitech Research, Avenue de Nenuphars 32, Auderghem 1160, Belgium. Germaine Hanquet has received personal fees from MSD, Sanofi Pasteur, Janssens, SNB, and Pfizer as speaker at an international meeting and as a member of advisory boards, outside the scope of the submitted work. Elizabeth Begier, Christian Theilacker, Bradford Gessner and Jeffrey Vietri are employees of Pfizer Inc. and may hold stocks or stock options.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.